Skip to main content

Peer Review reports

From: Cost-effectiveness of adding novel or group 5 interventions to a background regimen for the treatment of multidrug-resistant tuberculosis in Germany

Original Submission
9 Sep 2016 Submitted Original manuscript
8 Oct 2016 Reviewed Reviewer Report - Akiko Kowada
19 Jan 2017 Author responded Author comments - Daniel Wirth
Resubmission - Version 2
19 Jan 2017 Submitted Manuscript version 2
28 Jan 2017 Reviewed Reviewer Report - Akiko Kowada
13 Feb 2017 Author responded Author comments - Daniel Wirth
Resubmission - Version 3
13 Feb 2017 Submitted Manuscript version 3
Publishing
24 Feb 2017 Editorially accepted
8 Mar 2017 Article published 10.1186/s12913-017-2118-2

You can find further information about peer review here.

Back to article page